You are here: Industry Insights > Ebola

News List

New vaccine for prevention of Ebola virus disease recommended for approval in the EU expresspharma
June 01, 2020
The new Ebola vaccine consists of two components, Zabdeno (Ad26.ZEBOV) and Mvabea (MVA-BN-Filo). Zabdeno is given first and Mvabea is administered approximately eight weeks later as a booster.
Merck secures FDA authorisation for Ebola vaccine Ervebo pharmaceutical-technology
December 23, 2019
Merck (MSD) has received the US Food and Drug Administration (FDA) approval for its Ervebo vaccine to prevent Ebola virus disease (EVD) caused by Zaire ebolavirus.
J&J to provide 200,000 Ebola vaccine regimens to Rwanda europeanpharmaceuticalreview
December 10, 2019
Johnson & Johnson has announced that it will be contributing vaccines to support the Rwandan immunisation programme to combat Ebola.
DRC announces plans to use second Ebola vaccine europeanpharmaceuticalreview
September 24, 2019
Health authorities in the Democratic Republic of Congo are planning to use a second vaccine to treat the Ebola virus.
FDA accepts Biologics License Application for V920 Ebola vaccine europeanpharmaceuticalreview
September 20, 2019
A Biologics License Application and priority review has been approved by the FDA for an investigational Ebola vaccine.
Tiny Genetic Tweak May Stop Ebola Virus in Its Tracks drugs
September 19, 2019
New experiments in monkeys suggest that one slight alteration to the DNA of the Ebola virus might render it harmless to humans.
Ridgeback Biotherapeutics Breakthrough Therapy Designation for mAb114 americanpharmaceuticalreview
September 10, 2019
Ridgeback Biotherapeutics announced the Food and Drug Administration (FDA) has recently granted mAb114, an experimental treatment for Ebola, Breakthrough Therapy designation.
High Post-Hospital Death Rate Trails Ebola Survivors drugs
September 06, 2019
The overall death rate of the Ebola outbreak in West Africa may have been underestimated, with new research finding survivors could have a five times higher death rate after leaving the hospital than the general population.
CDC Boosts Efforts to Fight Congo Ebola Outbreak drugs
September 02, 2019
The U.S. Centers for Disease Control and Prevention has stepped up its efforts to help fight the Ebola outbreak in the Democratic Republic of the Congo (DRC).
$23m aid announced for Ebola vaccine manufacture europeanpharmaceuticalreview
August 23, 2019
The US HHS has committed to a contribution to help Merck manufacture its investigational V920 vaccine for the treatment of Ebola.

Previous page 1 2 3 4 5 6 7 Next page